stockportfolio.pro
Stocks / IMNM vs XRAY
IMNM vs XRAY
Immunome, Inc. and DENTSPLY SIRONA Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Immunome, Inc. (IMNM) | DENTSPLY SIRONA Inc. (XRAY) | |
|---|---|---|
| Market cap | $2.1B | $2.0B |
| Revenue (latest FY) | $6.94M | $3.68B |
| Net income (latest FY) | $-212.39M | $-598.00M |
| Revenue growth (5y CAGR) | — | 2.0% |
| Net margin | -3060.0% | -16.3% |
| Return on equity | -33.5% | -44.7% |
| P/E ratio | — | — |
| Dividend yield | — | 5.0% |
| Profitable years (of last 10) | 0 | 3 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open IMNM — free Open XRAY — freeFrequently asked questions
Which is bigger, IMNM or XRAY?
Immunome, Inc. is larger by market capitalization — $2.1B versus $2.0B.
Which grows faster, IMNM or XRAY?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.